The most recent guidance for CVS Health (CVS) was reported on February 10, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $7.00 to $7.20, compared to the estimated EPS of $7.16.

CVS Health (CVS) guided EPS in the range of $7.00 to $7.20 for the fiscal year 2026. The consensus analyst EPS estimate is $7.16.

CVS Health (CVS) guided revenue in the range of $400.00B to $400.00B for the fiscal year 2025.

CVS Health (CVS) maintained its EPS guidance from a prior range of $7.00 - $7.20 to $7.00 - $7.20 for the fiscal year 2026.

CVS Health (CVS) last issued guidance on February 10, 2026 for the fiscal year 2026.